Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26520 | 252 | 29.7 | 45% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
116 | 3 | MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS | 70215 |
2445 | 2 | TOXICOLOGIC PATHOLOGY//RASH2 MICE//HISTORICAL CONTROL DATA | 4057 |
26520 | 1 | DRUG INDUCED VASCULAR INJURY//ARTERIAL TOXICITY//MEDIAL NECROSIS | 252 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DRUG INDUCED VASCULAR INJURY | authKW | 861665 | 3% | 89% | 8 |
2 | ARTERIAL TOXICITY | authKW | 363516 | 1% | 100% | 3 |
3 | MEDIAL NECROSIS | authKW | 335547 | 2% | 46% | 6 |
4 | MEDIAL HEMORRHAGE | authKW | 242344 | 1% | 100% | 2 |
5 | TOXICOL COMPARAT MED | address | 218107 | 1% | 60% | 3 |
6 | CI 1044 | authKW | 161561 | 1% | 67% | 2 |
7 | PHYSIOL PAROI ARTERIELLE | address | 161561 | 1% | 67% | 2 |
8 | ACTIVATION AND DEGRANULATION OF MAST CELL | authKW | 121172 | 0% | 100% | 1 |
9 | ACTIVATION OF ENDOTHELIAL CELL AND MACROPHAGE | authKW | 121172 | 0% | 100% | 1 |
10 | AGE DEPENDENT ENDOTHELIAL DYSFUNCTION | authKW | 121172 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Toxicology | 3750 | 37% | 0% | 92 |
2 | Pathology | 3009 | 31% | 0% | 78 |
3 | Pharmacology & Pharmacy | 310 | 22% | 0% | 56 |
4 | Cardiac & Cardiovascular System | 150 | 11% | 0% | 27 |
5 | Medicine, General & Internal | 120 | 12% | 0% | 29 |
6 | Peripheral Vascular Diseases | 80 | 6% | 0% | 15 |
7 | Veterinary Sciences | 41 | 6% | 0% | 14 |
8 | Urology & Nephrology | 31 | 4% | 0% | 10 |
9 | Anatomy & Morphology | 27 | 2% | 0% | 4 |
10 | Emergency Medicine | 5 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TOXICOL COMPARAT MED | 218107 | 1% | 60% | 3 |
2 | PHYSIOL PAROI ARTERIELLE | 161561 | 1% | 67% | 2 |
3 | ANESTHET CRIT CARE ADDICT DRUG PROD HFD170 | 121172 | 0% | 100% | 1 |
4 | CARDIORENAL DRUG PROD HFD110 | 121172 | 0% | 100% | 1 |
5 | NEPHROL HYPERTENS DIALYSES | 121172 | 0% | 100% | 1 |
6 | PULM DRUG PROD HFD570 | 121172 | 0% | 100% | 1 |
7 | RECH SCI FORMAT RECH EVOLUT 3092 | 121172 | 0% | 100% | 1 |
8 | TOXICOL US | 121172 | 0% | 100% | 1 |
9 | BIOMARKER RD | 60585 | 0% | 50% | 1 |
10 | HOSP UNIV 12B | 60585 | 0% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TOXICOLOGIC PATHOLOGY | 109949 | 19% | 2% | 48 |
2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 3558 | 7% | 0% | 18 |
3 | BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY | 2254 | 2% | 0% | 4 |
4 | FUNDAMENTAL AND APPLIED TOXICOLOGY | 1427 | 2% | 0% | 5 |
5 | EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY | 1049 | 2% | 0% | 4 |
6 | VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY | 1018 | 2% | 0% | 4 |
7 | ARCHIVES OF TOXICOLOGY | 994 | 2% | 0% | 6 |
8 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 978 | 1% | 0% | 3 |
9 | TIERAERZTLICHE UMSCHAU | 943 | 1% | 0% | 3 |
10 | TOXICOLOGY LETTERS | 919 | 3% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DALMAS, DA , SCICCHITANO, MS , MULLINS, D , HUGHES-EARLE, A , TATSUOKA, K , MAGID-SLAV, M , FRAZIER, KS , THOMAS, HC , (2011) POTENTIAL CANDIDATE GENOMIC BIOMARKERS OF DRUG INDUCED VASCULAR INJURY IN THE RAT.TOXICOLOGY AND APPLIED PHARMACOLOGY. VOL. 257. ISSUE 2. P. 284-300 | 19 | 70% | 6 |
2 | BACARES, MEP , (2016) SAMPLING THE RAT MESENTERIC ARTERY: A SIMPLE TECHNIQUE.TOXICOLOGIC PATHOLOGY. VOL. 44. ISSUE 8. P. 1166 -1169 | 13 | 93% | 0 |
3 | JONES, HB , BJORKMAN, JA , SCHOFIELD, J , (2013) CORONARY AND SYSTEMIC ARTERIAL PHYSIOLOGY AND IMMUNOHISTOCHEMICAL MARKERS RELATED TO EARLY CORONARY ARTERIAL LESIONS IN BEAGLE DOGS GIVEN THE POTASSIUM CHANNEL OPENER, ZD6169, OR THE ENDOTHELIN RECEPTOR ANTAGONIST, ZD1611.TOXICOLOGIC PATHOLOGY. VOL. 41. ISSUE 5. P. 722-735 | 17 | 65% | 2 |
4 | MIKAELIAN, I , CAMERON, M , DALMAS, DA , ENERSON, BE , GONZALEZ, RJ , GUIONAUD, S , HOFFMANN, PK , KING, NMP , LAWTON, MP , SCICCHITANO, MS , ET AL (2014) NONCLINICAL SAFETY BIOMARKERS OF DRUG-INDUCED VASCULAR INJURY: CURRENT STATUS AND BLUEPRINT FOR THE FUTURE.TOXICOLOGIC PATHOLOGY. VOL. 42. ISSUE 4. P. 635 -657 | 46 | 21% | 6 |
5 | MECKLENBURG, L , HEUSER, A , JUENGLING, T , KOHLER, M , FOELL, R , OCKERT, D , TUCH, K , BODE, G , (2006) MESENTERITIS PRECEDES VASCULITIS IN THE RAT MESENTERY AFTER SUBACUTE ADMINISTRATION OF A PHOSPHODIESTERASE TYPE 4 INHIBITOR.TOXICOLOGY LETTERS. VOL. 163. ISSUE 1. P. 54-64 | 16 | 73% | 22 |
6 | BENDJAMA, K , GUIONAUD, S , ARAS, G , ARBER, N , BADIMON, L , BAMBERGER, U , BRATFALEAN, D , BROTT, D , DAVID, M , DOESSEGGER, L , ET AL (2014) TRANSLATION STRATEGY FOR THE QUALIFICATION OF DRUG-INDUCED VASCULAR INJURY BIOMARKERS.TOXICOLOGIC PATHOLOGY. VOL. 42. ISSUE 4. P. 658-671 | 24 | 38% | 3 |
7 | LOUDEN, C , MORGAN, DG , (2001) PATHOLOGY AND PATHOPHYSIOLOGY OF DRUG-INDUCED ARTERIAL INJURY IN LABORATORY ANIMALS AND ITS IMPLICATIONS ON THE EVALUATION OF NOVEL CHEMICAL ENTITIES FOR HUMAN CLINICAL TRIALS.PHARMACOLOGY & TOXICOLOGY. VOL. 89. ISSUE 4. P. 158-170 | 26 | 50% | 16 |
8 | FRAZIER, KS , ENGELHARDT, JA , FANT, P , GUIONAUD, S , HENRY, SP , LEACH, MW , LOUDEN, C , SCICCHITANO, MS , WEAVER, JL , ZABKA, TS , (2015) SCIENTIFIC AND REGULATORY POLICY COMMITTEE POINTS-TO-CONSIDER PAPER*: DRUG-INDUCED VASCULAR INJURY ASSOCIATED WITH NONSMALL MOLECULE THERAPEUTICS IN PRECLINICAL DEVELOPMENT: PART I. BIOTHERAPEUTICS.TOXICOLOGIC PATHOLOGY. VOL. 43. ISSUE 7. P. 915 -934 | 38 | 23% | 0 |
9 | HANTON, G , SOBRY, C , DAGUES, N , PROVOST, JP , LE NET, JL , COMBY, P , CHEVALIER, S , (2008) CHARACTERISATION OF THE VASCULAR AND INFLAMMATORY LESIONS INDUCED BY THE PDE4 INHIBITOR CI-1044 IN THE DOG.TOXICOLOGY LETTERS. VOL. 179. ISSUE 1. P. 15-22 | 18 | 56% | 9 |
10 | BROTT, DA , RICHARDSON, RJ , LOUDEN, CS , (2012) EVIDENCE FOR THE NITRIC OXIDE PATHWAY AS A POTENTIAL MODE OF ACTION IN FENOLDOPAM-INDUCED VASCULAR INJURY.TOXICOLOGIC PATHOLOGY. VOL. 40. ISSUE 6. P. 874-886 | 20 | 42% | 9 |
Classes with closest relation at Level 1 |